‘Psyched’: DC Includes Psychedelics Measure On Ballot, GreenStar Buys Eleusian, MindMed Wraps Clinical Trial

[ad_1]

District of Columbia To Include Psychedelics Decriminalization Measure on November Ballot

The District of Columbia will likely become the nation’s second jurisdiction to include a psychedelics decriminalization measure in November.

Oregon made a similar announcement last week, and will include psilocybin decriminalization on its ballot. In the case of DC, the ballot will also include ayahuasca and ibogaine, among others.

According to Decriminalize Nature DC, the activist organization behind the proposal, Initiative ...

Continue Reading →

Psychedelic drugs can greatly reduce psychiatric symptoms among special forces veterans, study finds

[ad_1]

A recent study published in Chronic Stress found support for a psychedelic treatment not yet approved in the United States. US Special Operations Forces (SOF) Veterans treated with ibogaine and 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) showed large reductions in symptoms of PTSD, depression, and anxiety.

Special Operations Forces (SOF) are members of the military who have been singled out for their superior “physical and psychological resilience.” Still, they ...

Continue Reading →
The Multibillion-Dollar Opioid Crisis Has a Plant Medicine Solution

The Multibillion-Dollar Opioid Crisis Has a Plant Medicine Solution | 2020-06-24 | Investing News

[ad_1]

Click to enlarge

(Image via Universal Ibogaine)

Investors and markets alike are getting excited about medicinal psychedelics, but this isn’t the first appearance for the plant-based medicinal wave. On the contrary, researchers at universities and government labs have been studying the positive therapeutic effects of psychedelics for years.

Most are familiar with psilocybin, ...

Continue Reading →
Page 14 of 50 «...101213141516...»
UA-77446339-1